1122-86-7

Usage

Uses

Used in Pharmaceutical Industry:
4-Ethoxy-piperidine >98% is used as an intermediate in the synthesis of various pharmaceuticals for its role in the production of antihistamines, analgesics, and other medicinal products. Its presence in these compounds contributes to their therapeutic effects.
Used in Organic Chemistry:
4-Ethoxy-piperidine >98% serves as a building block in the synthesis of complex organic molecules, facilitating the creation of a wide range of chemical compounds for various applications.

Upstream product

• 460367-82-2 tert-butyl 4-ethoxypiperidine-1-carboxylate 

Downstream Products

• 1174043-73-2 4-(3-(4-ethoxypiperidine-1-carbonyl)benzyl)phthalazin-1(2H)-one 
• 1174043-20-9 4-(3-(4-ethoxypiperidine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one 
• 1174043-76-5 4-(3-(4-ethoxypiperidine-1-carbonyl)benzyl)-5,7-dimethyl-2,6-dihydro-1H-pyrrolo[3,4-d]pyridazin-1-one 
• 1174044-03-1 5-chloro-4-(3-(4-ethoxypiperidine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one 
• 1174044-09-7 5-chloro-4-(3-(4-ethoxypiperidine-1-carbonyl)benzyl)phthalazin-1(2H)-one 
• 1174044-11-1 4-(3-(4-ethoxypiperidine-1-carbonyl)-4-fluorobenzyl)-5-methoxyphthalazin-1(2H)-one 
• 1174044-12-2 5-chloro-4-(3-(4-ethoxypiperidine-1-carbonyl)-5-fluorobenzyl)phthalazin-1(2H)-one 

Relevant academic research and scientific papers

ALKYNE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

Provided are compounds of formula (Ia) and pharmaceutically acceptable salts thereof, wherein A, B, R 1, R 2, m and n are as defined herein, which are active as inhibitors of S-Nitrosoglutathione reductase (GSNOR). These compounds prevent, inhibit, or suppress the action of GSNOR and are therefore useful in the treatment of GSNOR mediated diseases, disorders, syndromes or conditions such as, e.g., pulmonary hypertension, acute respiratory distress syndrome (ARDS), asthma, bronchospasm, cough, pneumonia, pulmonary fibrosis, interstitial lung diseases, cystic fibrosis and chronic obstructive pulmonary disease (COPD).

CHROMAN COMPOUNDS AS 5 -HTlB ANTAGONISTS

Chroman derivatives according to Formula (I) below: wherein R1, R2, R3 ,and R4 are as defined in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical .compositions containing a